Paul Sekhri, new CEO of vTv Therapeutics, touts potential for diabetes drug as he looks to turn biotech around – Triad Business Journal – The Business Journals
After three leadership change in less than six months, vTv Therapeutics (Nasdaq: VTVT) finally has a permanent CEO – one who says he is committed to getting the company back…